Related Experiment Video

Updated: Jul 5, 2026

Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-Based Reporter Assays
05:01

Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-Based Reporter Assays

Published on: June 14, 2024

Repair and translesion DNA polymerases as anticancer drug targets

Giovanni Maga1, Ulrich Hübscher

  • 1Ulrich Hübscher Institute for Veterinary Biochemistry and Molecular Biology, University of Zürich-Irchel, Winterthurerstrasse 190, Zürich, Switzerland.

Anti-Cancer Agents in Medicinal Chemistry
|May 14, 2008
PubMed

Insights

DNA polymerases are key enzymes in DNA metabolism and human diseases. Targeting DNA repair proteins and translesion DNA polymerases offers a promising strategy for developing novel anticancer drugs.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • DNA polymerases are crucial enzymes involved in DNA metabolism, including replication, repair, and synthesis.
  • Recent research highlights potential links between DNA polymerases and various human diseases.
  • Novel DNA polymerases have been identified, yet their precise cellular roles require further elucidation.

Purpose of the Study:

  • To review the roles of DNA polymerases in DNA metabolism and human diseases.
  • To explore DNA repair proteins and translesion DNA polymerases as potential therapeutic targets for cancer treatment.

Main Methods:

  • Literature review focusing on DNA polymerases, DNA repair, and translesion DNA synthesis.
  • Analysis of the functions of DNA polymerases in cellular processes.
  • Identification of potential drug targets within DNA repair and translesion DNA polymerase families.

Main Results:

  • DNA polymerases play fundamental roles beyond genome replication, including DNA repair and translesion synthesis.
  • Many DNA polymerases exhibit redundant functions.
  • Specific inhibition of certain DNA polymerases presents a viable strategy for anticancer drug development.

Conclusions:

  • DNA repair proteins and translesion DNA polymerases represent promising targets for novel anticancer therapies.
  • Targeting these enzymes could lead to the development of innovative cancer treatments.

More Related Videos

A Simple, Rapid, and Quantitative Assay to Measure Repair of DNA-protein Crosslinks on Plasmids Transfected into Mammalian Cells11:58

A Simple, Rapid, and Quantitative Assay to Measure Repair of DNA-protein Crosslinks on Plasmids Transfected into Mammalian Cells

Published on: March 5, 2018

Related Concept Videos

Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...